skip to main content





Back to all publications
Oct 23, 2018

Cannabis Legalization in Canada is Here

Answers to Your Most-Asked Cannabis in the Workplace Questions

By Michael F. Horvat

Q.        Does a company have to pay for an employee to attend a treatment program for addiction?

A.        No, a company is not required, as part of the accommodation process, to pay for an employee’s attendance at an addiction treatment program or to compensate that employee in any other manner for lost time. However, the employee may be entitled to certain insured benefits during his/her absence and attendance at treatment, since that individual remains and employee during the period of leave (subject to any restrictions already contained in your policies). The key obligation of the company is to allow the employee’s absence and facilitate his/her return to work upon successful completion of the program, without negative impact to his/her employment upon their return to work.

Q.        Can a company prohibit consumption of marijuana on or at their premises?

A.        First, since the webinar, the Ontario provincial government has expanded the permitted public spaces in which recreational cannabis can be consumed. However, this does not preclude a company from prohibiting the possession and/or consumption of marijuana on their property (and in Ontario, workplaces continue to be areas where open consumption of marijuana will be prohibited). Possession of medicinal marijuana could be an accommodation exception, but authorized use of medical marijuana at the workplace, particularly during the workday, will be subject to review and potential prohibition as undue hardship.

Q.        Can a company require disclosure by an employee of their use of marijuana?

A.        Where an employee has authorization to possess and consume medical marijuana, and it is reasonable to conclude that such use may impact the employee’s safe and productive performance of their duties, then such authorization should be disclosed (as with any other prescription drug use which may impact the safe and productive performance) and an accommodation review should be completed. If an employee is or suspects that he/she is suffering from addiction, such addiction concern, belief or diagnosis should be disclosed and the company should accommodate the treatment, recovery and return to work of that employee. There is likely no requirement for an employee to disclose his/her recreational use of a legal drug (such as marijuana or alcohol) on personal time, away from the workplace, provided such use does not affect his/her ability to attend at and perform their work safely and productively.

Areas of Expertise

Related Industries

Related Publications

Publications Article
Ontario’s Cannabis Regulations: Rushed to Release By Jeremy D. Burke Nov 16, 2018 The Ontario government has released General Regulation 468/18 (the Regulation) under the Cannabis Licence Act, 2018 (the Licence Act) and has announced that the Alcohol and Gaming Commission of Ontario (the AGCO) will begin accepting retail store applications (online only) on December 17, 2018.
Publications Article
Cameco Corporation v. The Queen: A Lesson in Sham and Canadian Transfer Pricing Adjustments By Jack Bernstein, Edward Miller and Tyler Brent Nov 13, 2018 On September 26, 2018, the Tax Court of Canada released its decision in Cameco Corporation v. The Queen. The case addressed the transfer pricing provisions contained in subsection 247(2) of the Income Tax Act (Canada) (the “Act”) and whether the transactions in question were a sham. In a win for ...
Publications Article
A Problem Crying out for an Early Resolution By Donald Carr Nov 13, 2018 The current wholesale upset of Ontario’s estates and trusts legal community over the decision in Re Milne is not only disturbing, but causes reflection on the origin of multiple wills in this province, as well as earnest hope for an early resolution of a huge problem.